{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:22:28Z","timestamp":1648981348377},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40291-015-0151-6","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T10:48:20Z","timestamp":1438166900000},"page":"251-252","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia"],"prefix":"10.1007","volume":"19","author":[{"given":"Mireille","family":"Crampe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Langabeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"3","key":"151_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40291-015-0139-2","volume":"19","author":"W Mattarucchi","year":"2015","unstructured":"Mattarucchi W, Pallotti F, Casalone R. Technical issues behind molecular monitoring in chronic myeloid leukemia. Mol Diagn Ther. 2015;19(3):139\u201340. doi: 10.1007\/s40291-015-0139-2 .","journal-title":"Mol Diagn Ther."},{"key":"151_CR2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.29","volume":"29","author":"NCP Cross","year":"2015","unstructured":"Cross NCP, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, et al. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia. 2015;29:999\u20131003.","journal-title":"Leukemia."},{"key":"151_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2011.08603.x","volume":"153","author":"L Foroni","year":"2011","unstructured":"Foroni L, Wilson G, Gerrard G, Mason J, Grimwade D, White HE, et al. Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. Br J Haematol. 2011;153:179\u201390.","journal-title":"Br J Haematol."},{"key":"151_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5858\/arpa.2011-0136-OA","volume":"136","author":"LJ Jennings","year":"2012","unstructured":"Jennings LJ, Smith FA, Halling KC, Persons DL, Kamel-Reid S. Design and analytical validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease. Arch Pathol Lab Med. 2012;136:33\u201340.","journal-title":"Arch Pathol Lab Med."},{"key":"151_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3324\/haematol.2010.034389","volume":"96","author":"JM Cayuela","year":"2011","unstructured":"Cayuela JM, Macintyre E, Darlington M, Abdelali RB, Fund X, Villarese P, et al. Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost? Haematologica. 2011;96:664\u201371.","journal-title":"Haematologica."},{"key":"151_CR6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00277-012-1468-4","volume":"91","author":"CE L\u00f3pez-Jorge","year":"2012","unstructured":"L\u00f3pez-Jorge CE, G\u00f3mez-Casares MT, Jim\u00e9nez-Velasco A, Garc\u00eda-Bello MA, Barrios M, Lopez J, et al. Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns. Ann Hematol. 2012;91:1245\u201350.","journal-title":"Ann Hematol."},{"key":"151_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.leukres.2013.11.016","volume":"38","author":"ME O\u2019Dwyer","year":"2014","unstructured":"O\u2019Dwyer ME, Swords R, Nagler A, McMullin MF, le Coutre PD, Langabeer SE, et al. Nilotinib 300mg BID as frontline treatment of CML: prospective analysis of the Xpert BCR-ABL monitor system and significance of 3 month molecular response. Leuk Res. 2014;38:310\u20135.","journal-title":"Leuk Res."},{"key":"151_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","volume":"16","author":"LJ Jennings","year":"2014","unstructured":"Jennings LJ, George D, Czech J, Yu M, Joseph L. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR. J Mol Diagn. 2014;16:174\u20139.","journal-title":"J Mol Diagn."},{"key":"151_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmoldx.2014.10.002","volume":"17","author":"PA Bartley","year":"2015","unstructured":"Bartley PA, Latham S, Budgen B, Ross DM, Hughes E, Branford S, et al. A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia. J Mol Diagn. 2015;17:185\u201392.","journal-title":"J Mol Diagn."},{"issue":"26","key":"151_CR10","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","volume":"125","author":"JJ Dongen Van","year":"2015","unstructured":"Van Dongen JJ, van der Velden VH, Br\u00fcggemann M, Orfao A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood. 2015;125(26):3996\u20134009. doi: 10.1182\/blood-2015-03-580027 .","journal-title":"Blood."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-015-0151-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0151-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T22:23:44Z","timestamp":1559514224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-015-0151-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1007\/s40291-015-0151-6","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}